This report, put together by the Toronto Drug Strategy, presents the results of focus groups for people who use alcohol and other drugs and their experiences of stigma and discrimination. Additionally, recommendations for action are made for the development of strategies to address stigma and discrimination toward this population.

The Rockefeller Institute's Stories from Sullivan series combines aggregate data analysis with on-the-ground research in affected communities to provide insight into what the opioid problem looks like in this rural county, how the community has responded, and what kinds of policies have the best chances of making a difference. 

This paper describes the strategies and policies implemented in Ohio to improve opioid safety and discusses the role that pharmacists can play in implementing, promoting, and enhancing the effectiveness of these policies. In particular, the Governor's Cabinet Opiate Action Team is discussed, which created and implemented a multifaceted strategy which significant reduced opioid prescribing the state. 

This is a report from the U.S. Interagency Council on Homelessness that identifies strategies communities, providers, and policymakers can use to address the intersection of homelessness and the opioid crisis and highlights several helpful resources developed by federal and national partners to support such efforts. 

This academic paper describes bridge clinics, which offer immediate, low barrier access to medications for opioid use disorder and other substance use disorder treatment, helping to close gaps in the continuum of care. It reviews available evidence for bridge clinic effectiveness in care delivery, including retention in treatment, while highlighting gaps in data on their effectiveness.

This database from the CDC allows users to examine prevalence of fatal overdoses for 28 states and the District of Columbia in 2020. Comprehensive information on decedents is given beyond what is available on a death certificate.  

This report describes the current distribution and funding mix for naloxone access and explores the potential impacts of policy changes to expand coverage for naloxone as a non-prescription product. It argues that non-prescription status for naloxone and education about its efficacy and availability would help reduce opioid overdose deaths in the US.

This academic paper outlines a study which investigated the impact of supervised injection facilities on individuals who use injected drugs. The authors implemented a systematic review of existing studies on this specific topic and concluded that supervised injection facilities reduce the risk of overdose morbidity and mortality and improve access to care. 

This is a report from the National Council on Mental Wellbeing that aims to help harm reduction organizations, treatment providers, and other organizations that serve people who use drugs overcome challenges associated with implementing telehealth and technology-assisted services and leverage these advances to help improve the health and wellness of the individuals they serve. Successful initiatives are highlighted throughout the report. 

A webpage by the Harm Reduction Coalition with documents, curriculum trainings, and other resources for building alliances with law enforcement to support syringe exchanges.  

This is the abstract of a peer-reviewed article about the implementation of evidence-based opioid interventions in the face of opposition. This paper uses the experience of the first syringe exchange in North Carolina, which is considered the first program of its kind in a red state.

This is an issue brief from the Baker Institute for Public Policy, written to influence policymakers in Texas, that gives an overview of the evidence for syringe service programs (SSP) and provides case studies of different states that have implemented SSPs.